Anaptysbio (ANAB) Total Debt (2016 - 2019)
Anaptysbio's (ANAB) quarterly Total Debt came in at $3.1 million in Q3 2019, up 28.68% YoY from $2.4 million in Q3 2018, and down 35.42% on a QoQ basis from $4.8 million in Q2 2019.
Anaptysbio (ANAB) Total Debt (2016 - 2019) Analysis & Trends
Anaptysbio (ANAB) has 4 years of Total Debt data on file, last reported at $3.1 million in Q3 2019.
- Quarterly Total Debt rose 28.68% year-over-year to $3.1 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $3.1 million (up 28.68% YoY) and the FY2018 annual result came in at $625000.0, down 91.73% from the prior year.
- Total Debt fell to $3.1 million in Q3 2019, from $4.8 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $13.8 million in Q4 2016 to a low of $625000.0 in Q4 2018.
- A 4-year average of $6.8 million and a median of $6.2 million in 2018 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2018 — Total Debt tumbled 91.73% — and 2019, when it rose 28.68%.
- Tracing ANAB's Total Debt over 4 years: stood at $13.8 million in 2016, then plunged by 45.3% to $7.6 million in 2017, then plunged by 91.73% to $625000.0 in 2018, then jumped by 396.0% to $3.1 million in 2019.
- The last three Total Debt figures came in at $3.1 million (Q3 2019), $4.8 million (Q2 2019), and $6.5 million (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Anaptysbio | 1.70 Bn | 1.41 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 3.10 Mn |
| Jun 30, 2019 | 4.80 Mn |
| Mar 31, 2019 | 6.50 Mn |
| Dec 31, 2018 | 625,000.00 |
| Sep 30, 2018 | 2.41 Mn |
| Jun 30, 2018 | 4.12 Mn |
| Mar 31, 2018 | 5.83 Mn |
| Dec 31, 2017 | 7.55 Mn |
| Sep 30, 2017 | 9.27 Mn |
| Jun 30, 2017 | 10.99 Mn |
| Mar 31, 2017 | 12.71 Mn |
| Dec 31, 2016 | 13.81 Mn |